Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanyog Jain

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
International Journal of Pharmaceutics|January 30, 2025
Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancerSimran Chandani, Sayali Dighe, Oly Katari, et al.
Carbohydrate Polymers|May 19, 2024
Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancerReena Sharma, Vivek Yadav, Shikha Jha, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 11, 2026
Cisplatin(IV)-fatty acid prodrug-bound albumin nanoparticles: In vitro, in silico, and in vivo evaluation in breast cancer therapyOly Katari, Vivek Yadav, R Rajkumar, et al.
International Journal of Biological Macromolecules|August 28, 2023
Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptakeBhargavi Nallamothu, Kaushik Kuche, Rohan Ghadi, et al.
Pharmaceutical Research|June 17, 2026
Transdermal Ionic Liquid Gel of Erlotinib for Localized Breast Cancer TherapyPaulami Datta, Oly Katari, Vivek Yadav, et al.
AAPS Pharmscitech|December 5, 2024
Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancerLavkesh Bhute, Sayali Dighe, Oly Katari, et al.
International Journal of Pharmaceutics|October 31, 2024
Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclaxTushar Date, Oly Katari, Kaushik Kuche, et al.
AAPS Pharmscitech|September 11, 2023
Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety AssessmentKaushik Kuche, Vivek Yadav, Meet Patel, et al.
Nanomedicine (London, England)|July 5, 2018
Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapySanyog Jain, Dnyaneshwar P Kale, Rajan Swami, et al.
Molecular Pharmaceutics|April 19, 2022
Understanding the Role of Axial Ligands in Modulating the Biopharmaceutical Outcomes of Cisplatin(IV) DerivativesTushar Date, Kaushik Kuche, Rohan Ghadi, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
International Journal of Pharmaceutics|January 30, 2025
Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancerSimran Chandani, Sayali Dighe, Oly Katari, et al.
Carbohydrate Polymers|May 19, 2024
Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancerReena Sharma, Vivek Yadav, Shikha Jha, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 11, 2026
Cisplatin(IV)-fatty acid prodrug-bound albumin nanoparticles: In vitro, in silico, and in vivo evaluation in breast cancer therapyOly Katari, Vivek Yadav, R Rajkumar, et al.
International Journal of Biological Macromolecules|August 28, 2023
Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptakeBhargavi Nallamothu, Kaushik Kuche, Rohan Ghadi, et al.
Pharmaceutical Research|June 17, 2026
Transdermal Ionic Liquid Gel of Erlotinib for Localized Breast Cancer TherapyPaulami Datta, Oly Katari, Vivek Yadav, et al.
AAPS Pharmscitech|December 5, 2024
Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancerLavkesh Bhute, Sayali Dighe, Oly Katari, et al.
International Journal of Pharmaceutics|October 31, 2024
Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclaxTushar Date, Oly Katari, Kaushik Kuche, et al.
AAPS Pharmscitech|September 11, 2023
Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety AssessmentKaushik Kuche, Vivek Yadav, Meet Patel, et al.
Nanomedicine (London, England)|July 5, 2018
Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapySanyog Jain, Dnyaneshwar P Kale, Rajan Swami, et al.
Molecular Pharmaceutics|April 19, 2022
Understanding the Role of Axial Ligands in Modulating the Biopharmaceutical Outcomes of Cisplatin(IV) DerivativesTushar Date, Kaushik Kuche, Rohan Ghadi, et al.
Pageof 22